Anteris Technologies Global Corp.
ASXAVR short interest collapsed 99.8% over one week to just 5 shares, near-negligible levels. Stock surged 40.3% weekly as selling pressure evaporated following FDA breakthrough designation for its DurAVR valve in late March.
Snapshot as of 26 Jun 2026
No long-form analysis yet for AVR. Pulse alerts and the live data picture are available on ORTEX.
Open AVR on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AVR — free to start on ORTEX.
Sign up for free →Open AVR on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live AVR data →